TRIM39R, but not TRIM39B, regulates type I interferon response

Biochemical and Biophysical Research Communications

Volumn 436, Issue 1, 2013, Pages 90-95

  Kurata, Riho ^a   Tajima, Atsushi ^b   Yonezawa, Tomo ^c,d   Inoko, Hidetoshi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Behcet's disease; Defense of viral infection; RPP21; TRIM39B; TRIM39R; Type I interferon response

Indexed keywords

INTERFERON; PEPTIDE; PROTEIN RPP21; TRIPARTITE MOTIF 39B; TRIPARTITE MOTIF 39R; UNCLASSIFIED DRUG;

ARTICLE; BEHCET DISEASE; EXON; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; VIRUS INFECTION;

EID: 84879164267     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.064     Document Type: Article

References (23)

1. Committee for the preparation of clinical treatment of ocular lesions related to Behcet's disease. Guidelines for the clinical management of ocular Behçet's disease. Nihon Ganka Gakkai Zasshi 2012, 116:394-426.
2. Gogus F., Fresko I., Elbir Y., Eksioglu-Demiralp E., Direskeneli H. Oxidative burst response to monosodium urate crystals in patients with Behçet's syndrome. Clin. Exp. Rheumatol. 2005, 23:S81-85.
3. Cattan D. MEFV mutation carriers and diseases other than familial mediterranean fever: proved and non-proved associations; putative biological advantage. Curr. Drug Targets: Inflamm. Allergy 2005, 4:105-112.
4. *51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthrit. Rheum. 2009, 61:1287-1296.
5. Mizuki N., Meguro A., Ota M., Ohno S., Shiota T., Kawagoe T., Ito N., Kera J., Okada E., Yatsu K., Song Y.W.E.B., Lee N., Kitaichi N., Namba K., Horie Y., Takeno M., Sugita S., Mochizuki M., Bahram S., Ishigatsubo Y., Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat. Genet. 2010, 41:703-706.
6. Kurata R., Nakaoka H., Tajima A., Hosomichi K., Shiina T., Meguro A., Mizuki N., Ohono S., Inoue I., Inoko H. TRIM39 and RNF39 are associated with Behçet's disease independently of HLA-B*51 and -A*26. Biochem. Biophys. Res. Commun. 2010, 401:533-537.
7. Remmers E.F., Cosan F., Kirino Y., Ombrello M.J., Abaci N., Satorius C., Le J.M., Yang B., Korman B.D., Cakiris A., Aglar O., Emrence Z., Azakli H., Ustek D., Tugal-Tutkun I., Akman-Demir G., Chen W., Amos C.I., Dizon M.B., Kose A.A., Azizlerli G., Erer B., Brand O.J., Kaklamani V.G., Kaklamanis P., Ben-Chetrit E., Stanford M., Fortune F., Ghabra M., Ollier W.E., Cho Y.H., Bang D., O'Shea J., Wallace G.R., Gadina M., Kastner D.L., Gül A. Genome-wide association study identifies variants in the MHC class I, IL10 and IL23R-IL12RB2 regions associated with Behçet's disease. Nat. Genet. 2010, 42:698-702.
8. Shimizu J., Takai K., Fujiwara N., Arimitsu N., Ueda Y., Wakisaka S., Yoshikawa H., Kaneko F., Suzuki T., Suzuki N. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease. Clin. Exp. Immunol. 2012, 168:68-74.
9. Lee S.I., Kwon H.J., Lee E.S., Yang B.C., Bang D., Lee S., Sohn S. Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virus-induced Behcet's disease symptoms in mice. Vaccine 2007, 25:7047-7055.
10. Kaneko F., Togashi A., Saito S., Sakuma H., Oyama N., Nakamura K., Yokota K., Oguma K. Behçet's disease (Adamantiades-Behçet's disease). Clin. Dev. Immunol. 2011, 681956.
11. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
12. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
13. Ozato K., Shin D.M., Chang T.H., Morse H.C. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 2008, 8:849-860.
14. Tsuchida T., Zou J., Saitoh T., Kumar H., Abe T., Matsuura Y., Kawai T., Akira S. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010, 33:765-776.
15. Pertel T., Hausmann S., Morger D., Züger S., Guerra J., Lascano J., Reinhard C., Santoni F.A., Uchil P.D., Chatel L., Bisiaux A., Albert M.L., Strambio-De-Castillia C., Mothes W., Pizzato M., Grütter M.G., Luban J. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365.
16. Roberts J.D., Chiche J.D., Kolpa E.M., Bloch D.B., Bloch K.D. CGMP-dependent protein kinase I interacts with TRIM39R, a novel Rpp 21 domain-containing TRIM protein. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293:L903-912.
17. Yonezawa T., Katoh K., Obara Y. Existence of GPR40 functioning in a human breast cancer cell line, MCF-7. Biochem. Biophys. Res. Commun. 2004, 314:805-809.
18. Orimo A., Yamagishi T., Tominaga N., Yamauchi Y., Hishinuma T., Okada K., Suzuki M., Sato M., Nogi Y., Suzuki H., Inoue S., Yoshimura K., Shimizu Y., Muramatsu M. Molecular cloning of testis-abundant finger protein/ring finger protein 23 (RNF23), a novel RING-B box-coiled coil-B30.2 protein on the class I region of the human MHC. Biochem. Biophys. Res. Commun. 2000, 276:45-51.
19. Lee S.S., Fu N.Y., Sukumaran S.K., Wan K.F., Wan Q., Yu V.C. TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process. Exp. Cell Res. 2009, 315:1313-1325.
20. Huang N.J., Zhang L., Tang W., Chen C., Yang C.S., Kornbluth S. The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1. J. Cell Biol. 2012, 197:361-367.
21. Zhang L., Mei Y., Fu N.Y., Guan L., Xie W., Liu H.H., Yu C.D., Yin Z., Yu V.C., You H. TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21. Proc. Natl. Acad. Sci. USA 2012, 109:20937-20942.
22. Zhang L., Huang N.J., Chen C., Tang W., Kornbluth S. Ubiquitylation of p53 by the APC/C inhibitor Trim39. Proc. Natl. Acad. Sci. USA 2012, 109:20931-20936.
23. Versteeg G.A., Rajsbaum R., Sánchez-Aparicio M.T., Maestre A.M., Valdiviezo J., Shi M., Inn K.S., Fernandez-Sesma A., Jung J., García-Sastre A. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 2013, 38:384-398.